- Home
- EXAS vs COLD Comparison
EXAS vs COLD Comparison
Compare EXAS & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- COLD
- Stock Information
- Founded
- EXAS 1995
- COLD 1903
- Country
- EXAS United States
- COLD United States
- Employees
- EXAS N/A
- COLD N/A
- Industry
- EXAS Medical Specialities
- COLD Real Estate Investment Trusts
- Sector
- EXAS Health Care
- COLD Real Estate
- Exchange
- EXAS Nasdaq
- COLD Nasdaq
- Market Cap
- EXAS 10.7B
- COLD 5.1B
- IPO Year
- EXAS N/A
- COLD 2018
- Fundamental
- Price
- EXAS $56.28
- COLD $16.57
- Analyst Decision
- EXAS Strong Buy
- COLD Buy
- Analyst Count
- EXAS 20
- COLD 12
- Target Price
- EXAS $70.68
- COLD $26.00
- AVG Volume (30 Days)
- EXAS 3.6M
- COLD 3.9M
- Earning Date
- EXAS 07-30-2025
- COLD 05-08-2025
- Dividend Yield
- EXAS N/A
- COLD 5.55%
- EPS Growth
- EXAS N/A
- COLD N/A
- EPS
- EXAS N/A
- COLD N/A
- Revenue
- EXAS $2,828,128,000.00
- COLD $2,626,425,000.00
- Revenue This Year
- EXAS $14.58
- COLD $4.59
- Revenue Next Year
- EXAS $12.75
- COLD $5.53
- P/E Ratio
- EXAS N/A
- COLD N/A
- Revenue Growth
- EXAS 11.57
- COLD N/A
- 52 Week Low
- EXAS $39.97
- COLD $16.29
- 52 Week High
- EXAS $72.83
- COLD $30.45
- Technical
- Relative Strength Index (RSI)
- EXAS 61.48
- COLD 33.97
- Support Level
- EXAS $55.26
- COLD $16.29
- Resistance Level
- EXAS $58.68
- COLD $16.88
- Average True Range (ATR)
- EXAS 1.98
- COLD 0.52
- MACD
- EXAS -0.14
- COLD -0.05
- Stochastic Oscillator
- EXAS 64.86
- COLD 12.53
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.